+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Breast Cancer"

Immuno-Oncology Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immuno-Oncology Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 197 Pages
  • Global
From
Molecular Oncology Market - Global Forecast 2025-2030 - Product Thumbnail Image

Molecular Oncology Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 186 Pages
  • Global
From
From
From
AI in Oncology Market 2026-2030 - Product Thumbnail Image

AI in Oncology Market 2026-2030

  • Report
  • May 2026
  • 307 Pages
  • Global
From
From
Artificial Intelligence in Oncology Market Report 2026 - Product Thumbnail Image

Artificial Intelligence in Oncology Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
AI in Oncology for Analytical Solutions Market Report 2026 - Product Thumbnail Image

AI in Oncology for Analytical Solutions Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
AI in Oncology - Global Strategic Business Report - Product Thumbnail Image

AI in Oncology - Global Strategic Business Report

  • Report
  • July 2026
  • 218 Pages
  • Global
From
Cancer Biopsy Market Forecast to 2033 - Product Thumbnail Image

Cancer Biopsy Market Forecast to 2033

  • Report
  • October 2025
  • 120 Pages
  • Global
From
Loading Indicator

The Breast Cancer market is a subset of the Women's Health market, focusing on the diagnosis, treatment, and prevention of breast cancer. It includes a range of products and services, from medical devices and pharmaceuticals to patient education and support. Breast cancer is the most common cancer among women worldwide, and the market is driven by the need to improve early detection and treatment outcomes. The Breast Cancer market is highly competitive, with a range of players from large multinationals to small start-ups. Companies in the market include Roche, Novartis, AstraZeneca, Pfizer, Merck, and Johnson & Johnson, as well as smaller players such as Myriad Genetics, Genomic Health, and Natera. Show Less Read more